This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of ForeseeHome (Notal Vision Inc.) for the detection of choroidal neovascularization (CNV) associated with conversion to neovascular age-related macular degeneration (nAMD).

If you have a Hayes login, click here to view the full report on the Knowledge Center.